CPT® Code 87622

Deleted

1. Indications

The procedure associated with CPT® Code 87622 is indicated for the detection and quantification of human papillomavirus (HPV) in patients who may be at risk for HPV-related diseases. The following conditions and symptoms may warrant the use of this test:

• High-risk HPV types Testing is performed to identify the presence of high-risk HPV types that are associated with an increased risk of developing cervical and other anogenital cancers.
• Abnormal Pap smear results Patients with abnormal findings on Pap smears may require further testing to determine the presence and quantity of HPV.
• Monitoring treatment response Quantification of HPV may be necessary to assess the effectiveness of treatment in patients undergoing therapy for HPV-related conditions.
• Screening in high-risk populations Individuals in high-risk groups, such as those with a history of multiple sexual partners or previous HPV infections, may be screened for HPV to evaluate their risk of developing related diseases.

2. Procedure

The procedure for CPT® Code 87622 involves several key steps to ensure accurate detection and quantification of HPV. The following outlines the procedural steps:

• Sample collection Samples are collected from the cervix, vagina, male urethra, or anus using appropriate swabs or brushes. This step is crucial as it ensures that the specimen contains the necessary cells for testing.
• Cell lysis The collected samples undergo a lysis process, where lysate is applied to rupture the cells and release the nucleic acids contained within. This step is essential for isolating the HPV genetic material for further analysis.
• Nucleic acid hybridization A single-stranded chemiluminescent DNA probe, which is complementary to the ribosomal RNA of the specific HPV type, is introduced to the lysate. The probe binds to the HPV nucleic acids, forming stable DNA:RNA hybrids.
• Detection of hybrids The presence of the DNA:RNA hybrids is detected using a luminometer, which measures the luminescence produced by the hybridization reaction. This detection method allows for the identification of HPV in the sample.
• Amplification (if necessary) If the initial testing indicates low levels of HPV, amplification techniques such as polymerase chain reaction (PCR) or transcription-mediated amplification (TMA) may be employed to increase the quantity of HPV nucleic acids, making them easier to detect.
• Quantification Finally, the amplified product is quantified to determine the number of HPV organisms present in the sample. This quantification provides valuable information regarding the severity of the infection and the patient's response to treatment.

3. Post-Procedure

After the completion of the HPV quantification procedure, patients may be advised on follow-up care based on the results obtained. If the test indicates the presence of high-risk HPV types, further evaluation and management may be necessary, which could include additional diagnostic procedures or treatment options. Patients should be informed about the importance of regular screenings and follow-up appointments to monitor their health status. Additionally, healthcare providers may discuss preventive measures, such as vaccination against HPV, to reduce the risk of future infections and associated complications.